Park National Corp’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$272K Sell
542
-25
-4% -$12K 0.01% 283
2026
Q1
$279K Buy
+567
New +$308K 0.01% 283
2024
Q3
Sell
-379
Closed -$210K 303
2024
Q2
$210K Buy
379
+23
+6% +$13.2K 0.01% 283
2024
Q1
$207K Buy
+356
New +$200K 0.01% 279
2023
Q2
Sell
-376
Closed -$217K 288
2023
Q1
$217K Buy
376
+6
+2% +$3.38K 0.01% 251
2022
Q4
$204K Buy
+370
New +$196K 0.01% 265
2018
Q3
Sell
-1,243
Closed -$258K 365
2018
Q2
$258K Sell
1,243
-103
-8% -$21.9K 0.01% 284
2018
Q1
$278K Buy
+1,346
New +$283K 0.02% 281

Other funds holding TMO

Park National Corp's TMO Position: Q2 2026 in Review

Park National Corp reduced its Thermo Fisher Scientific (TMO) stake by 4.4% in Q2 2026, selling an estimated $12K and leaving 542 shares worth $272K. The position accounts for 0.01% of the portfolio, ranked #283.

Park National Corp first reported a position in TMO in Q1 2018 and has held it in 8 quarters since. The position peaked at $279K in Q1 2026. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Park National Corp held 542 shares of Thermo Fisher Scientific worth $272K as of Q2 2026.
  • Park National Corp sold 25 Thermo Fisher Scientific shares in Q2 2026, an estimated $12K.
  • Thermo Fisher Scientific made up 0.01% of Park National Corp's portfolio in Q2 2026, its #283 holding.
  • Park National Corp first reported a position in Thermo Fisher Scientific in Q1 2018 and has held it in 8 quarters since.
  • Park National Corp's Thermo Fisher Scientific position peaked at $279K in Q1 2026.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Park National Corp's 13F filing for Q2 2026, filed 15 Jul 2026.